Powder: -20°C for 3 years | In solvent: -80°C for 1 year
InhA-IN-3 (TU13) is a potent inhibitor of Mycobacterium tuberculosis InhA (enoyl ACP reductase) with potential anticancer and antiproliferative activities for the study of Mycobacterium tuberculosis infections.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 350.00 | |
5 mg | In stock | $ 970.00 | |
10 mg | In stock | $ 1,200.00 | |
25 mg | In stock | $ 1,590.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,500.00 |
Description | InhA-IN-3 (TU13) is a potent inhibitor of Mycobacterium tuberculosis InhA (enoyl ACP reductase) with potential anticancer and antiproliferative activities for the study of Mycobacterium tuberculosis infections. |
Targets&IC50 | InhA:17.7 μM |
In vitro | InhA-IN-3 (Compound TU12) exhibits antitubercular activity against Mycobacterium tuberculosis, with a MIC of 0.78±0.59 µg/mL [1]. |
Molecular Weight | 321.78 |
Formula | C14H12ClN3O2S |
CAS No. | 900701-83-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
InhA-IN-3 900701-83-9 Microbiology/Virology Antibacterial inhibitor inhibit